Download PDF
CC BY 4.0 · Chinese medicine and natural products 2025; 05(01): e47-e58
DOI: 10.1055/s-0045-1807269
Original Article

Exploring the Mechanism of Yougui Pill against Aging Based on Network Pharmacology and Molecular Docking Study

Haiyan Yang
1   School of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine Nanchang, Jiangxi, China
,
Qian Shi
1   School of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine Nanchang, Jiangxi, China
,
Chunchun Ji
1   School of Traditional Chinese Medicine, Jiangxi University of Chinese Medicine Nanchang, Jiangxi, China
› Author Affiliations
Funding Jiangxi University of Traditional Chinese Medicine School-level Postgraduate Innovation Special Funds for Funding Projects (School Word [2023] No. 33); Jiangxi Province Traditional Chinese Medicine Young and Middle-aged Backbone Talent Training Program (Third Batch) Project (Gan Traditional Chinese Medicine Science and Education [2021] No. 4).
› Further Information
Also available at
  Permissions and Reprints

Abstract

Objective

This study aimed to explore the mechanism of obtaining yang from yin in Yougui pill against aging based on network pharmacology and molecular docking technology.

Methods

The active components and targets of Yougui Pill were obtained by searching the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database and the Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine (BATMEN-TCM) database, and kidney deficiency syndrome-related targets were obtained in the Symptom Mapping (SymMap) Database, a traditional Chinese medicine (TCM) syndrome correlation database. The protein–protein interaction (PPI) network was constructed by using the STRING11.5 database. Then, we used CytoScape3.9.0 software to construct the network of TCM–active components–potential targets, and the core TCM components and core targets of Yougui Pill for the treatment of kidney deficiency were obtained. The function analysis of Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway enrichment analysis were performed in the Database for Annotation, Visualization, and Integrated Discovery (DAVID). Finally, preliminary verification was performed with the help of molecular docking technology.

Results

A total of 147 active components of 9 drugs of Yougui Pill (Fuzi [Aconiti Lateralis Radix Praeparata], Shudihaung [Rehmanniae Radix Praeparata], Gouqi [Lycii Fructus], Shanyao [Rhizoma Dioscoreae], Shanzhuyu [Corni Fructus], Tusizi [Cuscutae Semen], Danggui [Angelicae Sinensis Radix], Duzhong [Eucommiae Cortex], Lujiaojiao [Cervi Cornus Colla]) were obtained, corresponding to 233 targets. A total of 2,235 targets related to kidney deficiency syndrome and 43 potential therapeutic targets were obtained after the intersection. The core TCM components mainly included quercetin, kaempferol, diosgenin, β-carotene, etc. The core targets involved Trp53 (Tp53), Akt1, Pparg, Nr3c1, App, Casp8, Mapk1, Cav1, and Ctnnb1. A total of 27 biological processes, 10 cellular components, and 11 molecular functions were obtained by gene function enrichment analysis, mainly related to the regulation of gene expression, cell apoptosis and proliferation, and the response to estrogen. A total of 51 KEGG signaling pathways, mainly involving a variety of cancer pathways, apoptosis pathways, longevity regulation pathways, etc.

Conclusion

Yougui Pill can play a role in preventing and treating kidney deficiency syndrome through multiple targets and pathways.

Keywords

Yougui Pill - aging - kidney deficiency syndrome - obtaining Yang from Yin - network pharmacology - molecular docking

CRediT Authorship Contribution Statement

Haiyan Yang: Conceptualization, data curation, funding acquisition, project administration, resources, supervision, and writing—original draft. Qian Shi: Formal analysis, investigation, methodology, validation, and writing—original draft. Chunchun Ji: Funding acquisition, methodology, project administration, software, and writing—review and editing.




Publication History

Received: 21 November 2024

Accepted: 29 January 2025

Article published online:
08 April 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 

  • References

  • 1 Li HR, Gao ML, Li YW. Investigation and analysis on the current status of cognition and application of aging and anti-aging with traditional Chinese medicine. Basic Tradit Chin Med 2023; 2 (09) 70-80
    Search in Google Scholar
  • 2 Zhang YQ, Li S. Some progress in modern research on network pharmacology and traditional Chinese medicine. Chinese Journal of Pharmacology and Toxicology 2015; 29 (06) 883-892
    Search in Google Scholar
  • 3 Liu D. Research progress and development prospects of network pharmacology [J]. Mod Econ Inf 2018; (20) 322
    Search in Google Scholar
  • 4 Lu F, Jiang X, Xu XM. Combining molecular docking and in vivo verification to explore the effect of Pangolin compound on TLR4/MyD88/NF-kB signaling pathway in gout model rats. Traditional Chinese Medicine Pharmacology and Clinical 2023; 39 (08) 25-31
    Search in Google Scholar
  • 5 Alam W, Khan H, Shah MA, Cauli O, Saso L. Kaempferol as a dietary anti-inflammatory agent: current therapeutic standing. Molecules 2020; 25 (18) 4073
    PubMedSearch in Google Scholar
  • 6 Wang LF, Gao YH, Xie GQ. Research progress on the mechanism of quercetin in improving osteoporosis. Modern Drugs and Clinic 2023; 38 (03) 714-718
    Search in Google Scholar
  • 7 Fu Z, Tian Y, Zhou X, Lan H, Wu S, Lou Y. Effects of quercetin on immune regulation at the maternal-fetal interface. Zhejiang Da Xue Xue Bao Yi Xue Ban 2023; 52 (01) 68-76 (Med Sci)
    PubMedSearch in Google Scholar
  • 8 Zhu LM, Guo ZQ, Ren YR. Effects of quercetin on reproductive damage in rats caused by n-hexane exposure. Chin Food 2022; (24) 99-101
    Search in Google Scholar
  • 9 Ge YL, Fan W, Tong ML. et al. Research progress of quercetin in the prevention and treatment of neurodegenerative diseases. Ginseng Res 2023; 35 (05) 56-58
    Search in Google Scholar
  • 10 Karimipour M, Rahbarghazi R, Tayefi H. et al. Quercetin promotes learning and memory performance concomitantly with neural stem/progenitor cell proliferation and neurogenesis in the adult rat dentate gyrus. Int J Dev Neurosci 2019; 74: 18-26
    PubMedSearch in Google Scholar
  • 11 Qiu ZH, Xie WY, Huang G. Effects of kaempferol on proliferation and apoptosis of osteoarthritis chondrocytes by regulating miR-21/SOX9. Chin Pharm 2022; 25 (12) 2073-2078
    Search in Google Scholar
  • 12 Imran M, Salehi B, Sharifi-Rad J. et al. Kaempferol: a key emphasis to its anticancer potential. Molecules 2019; 24 (12) 2277
    PubMedSearch in Google Scholar
  • 13 Bergsten TM, Li K, Lantvit DD, Murphy BT, Burdette JE. Kaempferol, a phytoprogestin, induces a subset of progesterone-regulated genes in the uterus. Nutrients 2023; 15 (06) 1407
    PubMedSearch in Google Scholar
  • 14 Lopez-Sanchez C, Poejo J, Garcia-Lopez V, Salazar J, Garcia-Martinez V, Gutierrez-Merino C. Kaempferol prevents the activation of complement C3 protein and the generation of reactive A1 astrocytes that mediate rat brain degeneration induced by 3-nitropropionic acid. Food Chem Toxicol 2022; 164: 113017
    PubMedSearch in Google Scholar
  • 15 Semwal P, Painuli S, Abu-Izneid T. et al. Diosgenin: an updated pharmacological review and therapeutic perspectives. Oxid Med Cell Longev 2022; 2022: 1035441
    CrossrefPubMedSearch in Google Scholar
  • 16 Song L, Li C, Wu F, Zhang S. Dietary intake of diosgenin delays aging of male fish Nothobranchius guentheri through modulation of multiple pathways that play prominent roles in ROS production. Biogerontology 2022; 23 (02) 201-213
    PubMedSearch in Google Scholar
  • 17 Chen CT, Wang ZH, Hsu CC, Lin HH, Chen JH. In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity. Nutrients 2015; 7 (06) 4938-4954
    CrossrefPubMedSearch in Google Scholar
  • 18 Shen M, Qi C, Kuang YP. et al. Observation of the influences of diosgenin on aging ovarian reserve and function in a mouse model. Eur J Med Res 2017; 22 (01) 42
    PubMedSearch in Google Scholar
  • 19 Qin JQ, Pang GF, Lv ZP. Progress in genetic research on life span differences between different genders. Chinese Geriatric Health Medicine 2015; 13 (02) 15-17
    Search in Google Scholar
  • 20 Fito-Lopez B, Salvadores M, Alvarez MM, Supek F. Prevalence, causes and impact of TP53-loss phenocopying events in human tumors. BMC Biol 2023; 21 (01) 92
    PubMedSearch in Google Scholar
  • 21 Li YN, Yang HY. Research progress on TP53-induced glycolysis and apoptosis regulatory factors in common cardiovascular diseases. Chin Med 2023; 18 (04) 599-602
    Search in Google Scholar
  • 22 Sasako T, Umehara T, Soeda K. et al. Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nat Commun 2022; 13 (01) 5655
    PubMedSearch in Google Scholar
  • 23 Zhang ZN, Liang LY, Lian JH. PI3K/AKT/mTOR signaling pathway in central nervous system. J Pract Med 2020; 36 (05) 689-694
    Search in Google Scholar
  • 24 Li RF, E QN, Wang CX. Nickel sulfate induces impaired testosterone synthesis in Leydig cells via inhibition of PI3K/Akt signaling pathway. J Toxicol 2023; 37 (02) 153-157 , 165
    Search in Google Scholar
  • 25 Baroi S, Czernik PJ, Chougule A, Griffin PR, Lecka-Czernik B. PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss. Bone 2021; 147: 115913
    PubMedSearch in Google Scholar
  • 26 Toffoli B, Gilardi F, Winkler C. et al. Nephropathy in Pparg-null mice highlights PPARγ systemic activities in metabolism and in the immune system. PLoS One 2017; 12 (02) e0171474
    CrossrefPubMedSearch in Google Scholar
  • 27 Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE. Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Br J Pharmacol 2008; 153 (04) 636-645
    PubMedSearch in Google Scholar
  • 28 Majithia AR, Flannick J, Shahinian P. et al.; GoT2D Consortium, NHGRI JHS/FHS Allelic Spectrum Project, SIGMA T2D Consortium, T2D-GENES Consortium. Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes. Proc Natl Acad Sci U S A 2014; 111 (36) 13127-13132
    PubMedSearch in Google Scholar
  • 29 Hsiao TJ, Lin E. The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma (PPARG) gene in relation to obesity and metabolic phenotypes in a Taiwanese population. Endocrine 2015; 48 (03) 786-793
    PubMedSearch in Google Scholar
  • 30 Zhang Y, Yang X, Bian F. et al. TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ. J Mol Cell Cardiol 2014; 72: 85-94
    PubMedSearch in Google Scholar